Arch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Up 22.1% in March

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 14,900 shares, an increase of 22.1% from the March 15th total of 12,200 shares. Based on an average trading volume of 1,800 shares, the days-to-cover ratio is currently 8.3 days. Currently, 0.3% of the company’s shares are sold short.

Arch Therapeutics Price Performance

ARTH stock opened at $0.20 on Monday. The firm’s fifty day moving average is $0.21 and its 200 day moving average is $0.23. Arch Therapeutics has a 52 week low of $0.16 and a 52 week high of $1.57.

About Arch Therapeutics

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.